Nemaline myopathy and heart failure: Role of ivabradine; a case report

BMC Cardiovascular Disorders

Volumn 15, Issue 1, 2015, Pages

  Sarullo, Filippo M ^a   Vitale, Giuseppe ^a   Di Franco, Antonino ^b   Sarullo, Silvia ^c   Salerno, Ylenia ^a   Vassallo, Laura ^c   Baviera, Emanuela Petrona ^c   Marazia, Stefania ^d   Mandalà, Giorgio ^a   Lanza, Gaetano A ^b  

^a Buccheri la Ferla Fatebenefratelli Hospital   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Giannuzzi Hospital   (Italy)

Author keywords

Dilated cardiomyopathy; Heart failure; Ivabradine; Nemaline myopathy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; ENALAPRIL; IVABRADINE; LOOP DIURETIC AGENT; SPIRONOLACTONE; BENZAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT;

ADULT; ANTERIOR CRUCIATE LIGAMENT RUPTURE; ARTICLE; ASPIRATION PNEUMONIA; CASE REPORT; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DISEASE COURSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ELECTROMYOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; MOTONEURON; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; NEMALINE MYOPATHY; PRIORITY JOURNAL; PROGNOSIS; REHABILITATION; RESTING HEART RATE; SHOULDER DISLOCATION; SHOULDER GIRDLE; SPIROMETRY; TRACHEOSTOMY; COMPLICATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; BENZAZEPINES; CARDIOVASCULAR AGENTS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART FAILURE; HUMANS; MALE; MYOPATHIES, NEMALINE; TREATMENT OUTCOME;

EID: 84925359991     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-15-5     Document Type: Article

References (28)

1. North KN, Laing NG, Wallgren-Pettersson C: Nemaline myopathy: current concepts. The ENMC International Consortium on Nemaline Myopathy. J Med Genet 1997, 34:705-713. 10.1136/jmg.34.9.705
2. Palmucci L, Doriguzzi C, Mongini T, Chiado-Piat L: Adult onset nemaline myopathy: a distinct nosologic entity? Clin Neuropathol 1993, 12:153-5.
3. Chahin N, Selcen D, Engel AG: Sporadic late onset nemaline myopathy. Neurology 2005, 65:1158-64. 10.1212/01.wnl.0000180362.90078.dc
4. Eymard B, Brouet JC, Collin H, Chevallay M, Bussel A, Fardeau M: Late-onset rod myopathy associated with monoclonal gammopathy. Neuromusc Disord 1993, 3:557-60. 10.1016/0960-8966(93)90115-Z
5. Keller CE, Hays AP, Rowland LP, Moghadaszadeh B, Beggs AH, Bhagat G: Adult-Onset nemaline myopathy and monoclonal gammopathy. Arch Neurol 2006, 63:132-13. 10.1001/archneur.63.1.132
6. Gatayama R, Ueno K, Nakamura H, Yanagi S, Hideaki U, Yamagishi H, Yasui S: Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics; 2013, 131:e1-e5. 10.1542/peds.2012-1106
7. Meier C, Gertsch M, Zimmermann A, Voellmy W, Geissbühler J: Nemaline myopathy in adults as a cardiomyopathy. A clinicopathologic study. NEJM 1983,308(25):1536.
8. Stoessl AJ, Hahn AF, Malott D, Jones DT, Silver MD: Nemaline myopathy with associated cardiomyopathy. Report of clinical and detailed autopsy findings. Arch Neurol 1985,42(11):1084-1086. 10.1001/archneur.1985.04060100070025
9. Nagata R, Kamimura D, Suzuki Y, Saito T, Toyama H, Dejima T, et al.: A case of nemaline myopathy with associated dilated cardiomyopathy and respiratory failure. Int Heart J 2011, 52:401-405. 10.1536/ihj.52.401
10. Lomen-Hoerth C, Simmons ML, Dearmond SJ, Layzer RB: Adult-onset nemaline myopathy: another cause of dropped head. Muscle Nerve 1999,22(8):1146-1150. 10.1002/(SICI)1097-4598(199908)22:8<1146::AID-MUS23>3.0.CO;2-U
11. Engel WK, Oberc MA: Abundant nuclear rods in adult onset rod disease. J Neuropathol Exp Neurol 1975, 34:119-132. 10.1097/00005072-197503000-00001
12. Gyure KA, Prayson RA, Estes ML: Adult-onset nemaline myopathy: a case report and review of the literature. Arch Pathol Lab Med 1997,121(11):1210-1213.
13. Kannel WB, Kannel C, Paffenbarger RSJR, Cupples LA: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987,113(6):1489-94. 10.1016/0002-8703(87)90666-1
14. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M: Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007,50(9):823-30. 10.1016/j.jacc.2007.04.079
15. Kjekshus J, Gullestad L: Heart rate as a therapeutic target in heart failure. Eur Heart J 1999,1(Suppl H):H64-9.
16. Greene SJ, Vaduganathan M, Wilcox JE, Harinstein ME, Maggioni AP, Subacius H, et al.: The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhytm. Insights from the EVEREST (Efficacy of Valpression Antagonism in Herat Fialure: Outcome Study With Tolvaptan) Trial. J Am Coll Cardiol HF 2013, 1:488-496.
17. Habal MV, Liu PP, Austin PC, Ross HJ, Newton GE, Wang X, et al.: Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure. Circ Heart Fail 2014, 7:12-20. 10.1161/CIRCHEARTFAILURE.113.000429
18. CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999, 353:9-13.
19. Willwnheimer R, van Veldhuisen DJ, Silke B, Erdmann E, Follath F, Krum H, CIBIS III Investigators, et al.: Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III. Circulation 2005,112(16):2426-35. 10.1161/CIRCULATIONAHA.105.582320
20. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, et al.: Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 1996,94(11):2807-16. 10.1161/01.CIR.94.11.2807
21. Fiuzat M, Wojdyla D, Kitzman D, Fleg J, Keteyian SJ, Kraus WE, et al.: Relationship of beta-blocker dose with outcomes in ambulatory heart failure patients with systolic dysfunction: results from the HF-ACTION (Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training) trial. J Am Coll Cardiol. 2012, 60:208-15. 10.1016/j.jacc.2012.03.023
22. McAlister FA, Wiebe N, Ezekowitz JA, Leung AA, Armstrong PW: Meta-analysis: beta-blocker dose, heart rate reduction, and death in patientss with heart failure. Ann Intern Med 2009,150(11):784-94. 10.7326/0003-4819-150-11-200906020-00006
23. Flannery G, Gehrig-Mills R, Billah B, Krum H: Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 2008,101(6):865-9. 10.1016/j.amjcard.2007.11.023
24. Di Franco A, Sarullo FM, Salerno Y, Figliozzi S, Parrinello R, Di Pasquale P, Lanza GA: Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice. Am J Cardiovasc Drugs 2014,14(2):101-110. 10.1007/s40256-013-0057-9
25. Sarullo FM, Fazio G, Puccio D, Fasullo S, Paterna S, Novo S, Di Pasquale P: Impact of "Off-Label" use of Ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure. J Cardiovasc Pharmac Ther 2010, 15:349-355. 10.1177/1074248410370326
26. Swedberg K, Komajda M, Böhm M, Borer J, Robertson M, Tavazzi L, Ford I, for the SHIFT Investigators: Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose? J Am Coll Cardiol 2012, 59:1938-1945. 10.1016/j.jacc.2012.01.020
27. Taglia A, D'Ambrosio P, Palladino A, Politano L: On a case of respiratory failure due to diaphragmatic paralysis and dilated cardiomyopathy in a patient with nemaline myopathy. Acta Myologica 2012, XXXI:201-203.
28. The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2261/15/5/prepub